— Know what they know.
Not Investment Advice
Also trades as: 0HKD.L (LSE) · $vol 0M

AXGN NASDAQ

AxoGen, Inc.
1W: +0.9% 1M: +11.7% 3M: +17.0% YTD: +33.3% 1Y: +257.0% 3Y: +348.5% 5Y: +92.4%
$40.90
-0.41 (-0.99%)
 
Weekly Expected Move ±6.2%
$36 $38 $41 $44 $46
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 64 · $2.2B mcap · 52M float · 2.06% daily turnover · Short 47% of daily vol

Cash Flow Trends

Operating Cash Flow
$812K -82.1% ▼
Capital Expenditures
$4M +17.2% ▲
5Y CAGR: -30.2%
Free Cash Flow
-$3M -26763.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$6M +272.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$27M-$29M-$22M-$10M-$16M
Depreciation & Amort.$5M$5M$6M$8M$8M
Stock-Based Comp.$11M$16M$14M$16M$30M
Change in Working Capital-$6M-$10M-$4M-$10M-$25M
Other Non-Cash Items$831K$2M$415K$797K$3M
Operating Cash Flow-$13M-$16M-$6M$5M$812K
— Investing Activities —
Capital Expenditures-$28M-$21M-$14M$0-$4M
Acquisitions (Net)-$589K$3M$0$0$0
Investment Purchases-$69M-$39M-$10M$0-$14M
Investment Sales$72M$57M$44M$0$14M
Other Investing$2M-$3M-$1M-$10M-$2M
Investing Cash Flow-$24M-$3M$19M-$10M-$5M
— Financing Activities —
Net Debt Issuance$15M-$12K-$10K-$10K-$32K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$20M$2M$2M$2M$10M
Net Change in Cash-$17M-$17M$15M-$3M$6M
Cash End of Period$39M$22M$37M$34M$40M
Free Cash Flow-$42M-$37M-$21M$11K-$3M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms